Cite
Bosly A, Guillaume T, Brice P, et al. Effects of escalating doses of recombinant human interleukin-2 in correcting functional T-cell defects following autologous bone marrow transplantation for lymphomas and solid tumors. Exp Hematol. 1992;20(8):962-8
Bosly, A., Guillaume, T., Brice, P., Humblet, Y., Staquet, P., Doyen, C., Chatelain, B., Franks, C. R., Gisselbrecht, C., & Symann, M. (1992). Effects of escalating doses of recombinant human interleukin-2 in correcting functional T-cell defects following autologous bone marrow transplantation for lymphomas and solid tumors. Experimental hematology, 20(8), 962-8.
Bosly, A, et al. "Effects of escalating doses of recombinant human interleukin-2 in correcting functional T-cell defects following autologous bone marrow transplantation for lymphomas and solid tumors." Experimental hematology vol. 20,8 (1992): 962-8.
Bosly A, Guillaume T, Brice P, Humblet Y, Staquet P, Doyen C, Chatelain B, Franks CR, Gisselbrecht C, Symann M. Effects of escalating doses of recombinant human interleukin-2 in correcting functional T-cell defects following autologous bone marrow transplantation for lymphomas and solid tumors. Exp Hematol. 1992 Sep;20(8):962-8. PMID: 1354620.
Copy
Download .nbib